Found: 15
Select item for more details and to access through your institution.
Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20.
- Published in:
- Endocrine Pathology, 2018, v. 29, n. 3, p. 236, doi. 10.1007/s12022-018-9516-9
- By:
- Publication type:
- Article
Novel Mechanistic Insights into Arginine Deiminase Pharmacology Suggest <sup>18</sup>F-FDG Is Not Suitable to Evaluate Clinical Response in Melanoma.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 2, p. 281, doi. 10.2967/jnumed.111.092973
- By:
- Publication type:
- Article
Differential expression of argininosuccinate synthetase in serous and non‐serous ovarian carcinomas.
- Published in:
- Journal of Pathology: Clinical Research, 2015, v. 1, n. 1, p. 41, doi. 10.1002/cjp2.4
- By:
- Publication type:
- Article
Phase II Study of Arginine Deprivation Therapy With Pegargiminase in Patients With Relapsed Sensitive or Refractory Small-cell Lung Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 24, p. 4585, doi. 10.1002/cncr.33870
- By:
- Publication type:
- Article
A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma.
- Published in:
- Pigment Cell & Melanoma Research, 2022, v. 35, n. 4, p. 461, doi. 10.1111/pcmr.13042
- By:
- Publication type:
- Article
Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients.
- Published in:
- Kidney International, 1984, v. 26, n. 5, p. 733, doi. 10.1038/ki.1984.209
- By:
- Publication type:
- Article
A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Argininosuccinate synthetase (ASS) deficiency in high-grade pulmonary neuroendocrine carcinoma: an opportunity for personalized targeted therapy.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2015, v. 141, n. 8, p. 1363, doi. 10.1007/s00432-014-1904-z
- By:
- Publication type:
- Article
Imaging of Tumor Vascularization Using Fluorescence Molecular Tomography to Monitor Arginine Deiminase Treatment in Melanoma.
- Published in:
- Molecular Imaging, 2013, v. 12, n. 1, p. 67, doi. 10.2310/7290.2012.00009
- By:
- Publication type:
- Article
Phase I study of ADI‐PEG20 plus low‐dose cytarabine for the treatment of acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 9, p. 2946, doi. 10.1002/cam4.3871
- By:
- Publication type:
- Article
Pegylated arginine deiminase lowers hepatitis C viral titers and inhibits nitric oxide synthesis.
- Published in:
- Journal of Gastroenterology & Hepatology, 2007, v. 22, n. 1, p. 86, doi. 10.1111/j.1440-1746.2006.04463.x
- By:
- Publication type:
- Article
Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2638, doi. 10.3390/cancers14112638
- By:
- Publication type:
- Article
Evaluation of arginine deiminase treatment in melanoma xenografts using (18)F-FLT PET.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Evaluation of Arginine Deiminase Treatment in Melanoma Xenografts Using <sup>18</sup>F-FLT PET.
- Published in:
- Molecular Imaging & Biology, 2013, v. 15, n. 6, p. 768, doi. 10.1007/s11307-013-0655-6
- By:
- Publication type:
- Article